CCMW
AMED

Cypress Capital Management (Wyoming)’s Amedisys AMED Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-13,146
Closed -$2.19M – 177
2019
Q4 		$2.19M Buy
+13,146
New +$1.96M 2.07% 19
2019
Q1 		– Sell
-5,010
Closed -$587K – 275
2018
Q4 		$587K Sell
5,010
-1,020
-17% -$120K 1.13% 25
2018
Q3 		$754K Buy
+6,030
New +$666K 0.76% 38

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s AMED Position: Q1 2020 in Review

Cypress Capital Management (Wyoming) sold out of Amedisys (AMED) in Q1 2020, closing a stake of 13,146 shares — an estimated $2.19M sold.

Cypress Capital Management (Wyoming) first reported a position in AMED in Q3 2018 and held it in 3 quarters. The position peaked at $2.19M in Q4 2019. 332 funds tracked by Wall St. Rank hold AMED as of Q1 2020.

  • Cypress Capital Management (Wyoming) reported no remaining Amedisys position as of Q1 2020 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 13,146 Amedisys shares in Q1 2020, an estimated $2.19M.
  • Cypress Capital Management (Wyoming) first reported a position in Amedisys in Q3 2018 and held it in 3 quarters.
  • Cypress Capital Management (Wyoming)'s Amedisys position peaked at $2.19M in Q4 2019.
  • 332 funds tracked by Wall St. Rank held Amedisys as of Q1 2020.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q1 2020, filed 6 May 2020.